TABLE 2.
Baseline characteristics of 50 hyperlipidemic volunteers in phase 2.
| Parameters | Control (n = 25) | 250 mg OPP (n = 25) | p |
|---|---|---|---|
| Gender/Sex | |||
| Male (n) | 11 | 10 | 0.774 |
| Female (n) | 14 | 15 | |
| Age (years) | 33.8 ± 7.4 | 33.5 ± 6.3 | 0.861 |
| BMI (kg.m−2) | 27.29 ± 5.12 | 28.31 ± 7.18 | 0.566 |
| Systolic (mmHg) | 122.4 ± 11.4 | 124.6 ± 13.3 | 0.532 |
| Diastolic (mmHg) | 79.6 ± 10.9 | 79.1 ± 8.7 | 0.864 |
| Total cholesterol (mmol/L) | 5.78 ± 0.52 | 5.76 ± 0.54 | 0.895 |
| LDL (mmol/L) | 3.88 ± 0.51 | 3.82 ± 0.59 | 0.664 |
| HDL (mmol/L) | 1.30 ± 0.25 | 1.37 ± 0.34 | 0.409 |
| Triglycerides (mmol/L) | 1.30 ± 0.82 | 1.25 ± 0.54 | 0.808 |
Abbreviations: BMI, body mass index; LDL, low-density lipoprotein; HDL, high-density lipoprotein. Data are tabulated as mean ± standard deviation or n.